Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/02/19 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 06/27/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/27/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/25/19 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
7 | |
| 06/25/19 | 8-K | Current report filing |
|
6 | |
| 06/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/12/19 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
45 | |
| 06/11/19 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/07/19 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
65 | |
| 06/04/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
